Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Anxin Pharmaceutical is a major Chinese pharmaceutical manufacturer and a core subsidiary of the Qilu Pharmaceutical Group. Based in Jinan, the company operates extensive production facilities for Active Pharmaceutical Ingredients (APIs) and finished dosage forms, specializing in anti-infectives, oncology, and cardiovascular therapies. Its manufacturing sites are compliant with international standards, including US FDA and EU GMP, supporting a robust export business to over 70 countries. As a key pillar of the Qilu Group, Shandong Anxin focuses on large-scale production of essential medicines, particularly cephalosporin antibiotics. The company plays a vital role in the global supply chain for generic drugs and high-purity chemical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Anxin.